Literature DB >> 17573586

Pathophysiology of coronary artery in-stent restenosis.

A Kibos1, A Campeanu, I Tintoiu.   

Abstract

In-stent restenosis reflects the interaction of a cascade of molecular and cellular events occurring within the vessel wall. Coronary stenting induces localized injury to the vessel wall, which leads to the release of thrombogenic, vasoactive, and lymphocytes mitogenic factors that result in processes causing re-narrowing at the injured site. Three major processes have been identified that lead to the in-stent restenosis: neointimal hyperplasia, elastic recoil, and negative arterial remodeling. The most important one is intimal hyperplasia. As the time course of neointimal hyperplasia is unknown, a causal relationship between the development of new blood vessels and clinical restenosis cannot be firmly established.

Entities:  

Mesh:

Year:  2007        PMID: 17573586     DOI: 10.1080/17482940701263285

Source DB:  PubMed          Journal:  Acute Card Care        ISSN: 1748-2941


  15 in total

1.  Blood Pressure Levels at the Time of Percutaneous Coronary Revascularization and Risk of Coronary In-Stent Restenosis.

Authors:  Giuliano Tocci; Emanuele Barbato; Roberta Coluccia; Anna Modestino; Beniamino Pagliaro; Vittoria Mastromarino; Francesca Giovannelli; Andrea Berni; Massimo Volpe
Journal:  Am J Hypertens       Date:  2015-08-13       Impact factor: 2.689

2.  Temporal correlation between wall shear stress and in-stent stenosis after Wingspan stent in swine model.

Authors:  M Fujimoto; H Takao; T Suzuki; Y Shobayashi; F Mayor; S Tateshima; M Yamamoto; Y Murayama; F Viñuela
Journal:  AJNR Am J Neuroradiol       Date:  2013-11-14       Impact factor: 3.825

Review 3.  Genetic causation of neointimal hyperplasia in hemodialysis vascular access dysfunction.

Authors:  Timmy Lee; Davinder Wadehra
Journal:  Semin Dial       Date:  2011-09-15       Impact factor: 3.455

4.  Mechanical properties and in vivo performance of a novel sliding-lock bioabsorbable poly-p-dioxanone stent.

Authors:  Qimao Feng; Wenbo Jiang; Kun Sun; Kang Sun; Sun Chen; Lijiao Zhao; Ke Dai; Ning Ma
Journal:  J Mater Sci Mater Med       Date:  2011-08-06       Impact factor: 3.896

5.  Sry-type HMG box 18 contributes to the differentiation of bone marrow-derived mesenchymal stem cells to endothelial cells.

Authors:  Izuagie Attairu Ikhapoh; Christopher J Pelham; Devendra K Agrawal
Journal:  Differentiation       Date:  2015-04-23       Impact factor: 3.880

6.  Different responses of cell cycle between rat vascular smooth muscle cells and vascular endothelial cells to paclitaxel.

Authors:  Liang Jing; Xi Peng; Min-Jie Xie; Zhi-Yuan Yu; Wei Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-06-18

7.  Sodium ferulate inhibits neointimal hyperplasia in rat balloon injury model.

Authors:  Jing Zhang; Jing Chen; Jian Yang; Changwu Xu; Jiawang Ding; Jun Yang; Qing Guo; Qi Hu; Hong Jiang
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

8.  Stratification of coronary artery disease patients for revascularization procedure based on estimating adverse effects.

Authors:  Sebastian Pölsterl; Maneesh Singh; Amin Katouzian; Nassir Navab; Adnan Kastrati; Lance Ladic; Ali Kamen
Journal:  BMC Med Inform Decis Mak       Date:  2015-02-14       Impact factor: 2.796

Review 9.  Beta-glucans in the treatment of diabetes and associated cardiovascular risks.

Authors:  Jiezhong Chen; Kenneth Raymond
Journal:  Vasc Health Risk Manag       Date:  2008

10.  Preventive effects of basic fibroblast growth factor on vascular restenosis after balloon angioplasty.

Authors:  Feng Ran; Changjian Liu; Zhao Liu; Tao Shang; Min Zhou; Tong Qiao
Journal:  Exp Ther Med       Date:  2014-02-19       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.